Who is sponsoring NCT03079245?

NCT03079245 is sponsored by Columbia University.

What drugs are being tested in NCT03079245?

Interventions in NCT03079245: Education Plus (E+), Clinical Decision Support, Prescriber Audit and Feedback.

What condition does NCT03079245 study?

NCT03079245 studies Infants in Neonatal Intensive Care Units.

Is NCT03079245 still recruiting?

NCT03079245 is currently completed. Last updated 14 March 2017.

Last reviewed 2017-03-14 · How we verify

NCT03079245: iNAP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improving Antimicrobial Prescribing Practices in the Neonatal ICU

Completed NA Last updated 14 March 2017

What this trial tests

NA trial testing Education Plus (E+) in Infants in Neonatal Intensive Care Units in 6,184 participants. Completed in 30 April 2012.

Timeline

1 May 2009

Primary endpoint
30 April 2012

30 April 2012

Quick facts

Lead sponsor	Columbia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	6,184
Start date	1 May 2009
Primary completion	30 April 2012
Estimated completion	30 April 2012
Sites	4 locations across United States

Drugs / interventions tested

Education Plus (E+)
Clinical Decision Support
Prescriber Audit and Feedback

Conditions studied

Infants in Neonatal Intensive Care Units — all drugs for Infants in Neonatal Intensive Care Units →

Sponsor

Columbia University

Who can join

Eligibility, any sex, with Infants in Neonatal Intensive Care Units. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine if 3 randomly assigned bundles of stewardship interventions would reduce overall and inappropriate antimicrobial use in the neonatal intensive care unit (NICU), a pre-post study was performed in 4 NICUs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Columbia University trials

Trials by the same sponsor.

NCT06558422 — Human Models of Selective Insulin Resistance: Pancreatic Clamp · Phase 1 · not yet recruiting
NCT07264582 — HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking · NA · not yet recruiting
NCT05992415 — Know Your Pressures NYC · NA · not yet recruiting
NCT05645211 — The AgRP and GH/IGF-1 Axis in Children · not yet recruiting
NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03079245 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Columbia University
Last refreshed: 14 March 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03079245.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing